CompaniesFKD Therapies

FKD Therapies

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

197

By Phase

PHASE3: 1PHASE2: 1

By Status

COMPLETED: 2

Recent Trials

NCT02773849Collaborator
ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
PHASE3Completed
157 participants
Started: Sep 19, 2016 · Completed: May 24, 2023
NCT01687244Lead Sponsor
Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer
PHASE2Completed
40 participants
Started: Sep 30, 2012 · Completed: Jan 31, 2016
FKD Therapies | Biotech Hunter | Biotech Hunter